Exploring the Causal Roles of Circulating Remnant Lipid Profile on Cardiovascular and Cerebrovascular Diseases: Mendelian Randomization Study

被引:31
作者
Si, Shucheng [1 ]
Hou, Lei [1 ]
Chen, Xiaolu [1 ]
Li, Wenchao [1 ]
Liu, Xinhui [1 ]
Liu, Congcong [1 ]
Li, Yunxia [1 ]
Yuan, Tonghui [1 ]
Li, Jiqing [1 ]
Wang, Bojie [1 ]
Li, Hongkai [1 ,2 ]
Xue, Fuzhong [1 ,2 ,3 ]
机构
[1] Shandong Univ, Sch Publ Hlth, Dept Biostatist, Cheeloo Coll Med, 44 Wenhuaxi Rd, Jinan 250012, Peoples R China
[2] Shandong Univ, Inst Med Dataol, Jinan, Peoples R China
[3] Natl Inst Hlth Data Sci China, Jinnan, Peoples R China
基金
中国国家自然科学基金;
关键词
remnant lipids; coronary heart disease; ischemic stroke; Mendelian randomization; DENSITY-LIPOPROTEIN CHOLESTEROL; TRIGLYCERIDE-RICH LIPOPROTEINS; ACUTE MYOCARDIAL-INFARCTION; RISK-FACTORS; GENETIC-VARIANTS; ASSOCIATION; METAANALYSIS; RABBITS; PLASMA;
D O I
10.2188/jea.JE20200305
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Causal evidence of circulating lipids especially the remnant cholesterol with cardiovascular and cerebrovascular disease (CVD) is lacking. This research aimed to explore the causal roles of extensive lipid traits especially the remnant lipids in CVD. Methods: Two-sample Mendelian randomization (TSMR) analysis was performed based on large-scale meta-analysis datasets in European ancestry. The causal effect of 15 circulating lipid profiles including 6 conventional lipids and 9 remnant lipids on coronary heart disease (CHD) and ischemic stroke (IS), as well as the subtypes, was assessed. Results: Apolipoprotein B (Apo B), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and triglyceride (TG) were still important risk factors for CHD and myocardial infarction (MI) but not for IS. Apo B is the strongest which increased the CHD and MI risk by 44% and 41%, respectively. The odds ratios (ORs) of total TG on CHD and MI were 1.25 (95% confidence interval [CI], 1.13-1.38) and 1.24 (95% CI, 1.11-1.38), respectively. A one standard deviation difference increased TG in medium very-low-density lipoproteins (M.VLDL.TG), TG in small VLDL (S.VLDL.TG), TG in very small VLDL (XS.VLDL.TG), TG in intermediate-density lipoproteins (IDL.TG), TG in very large HDL (XL.HDL.TG), and TG in small HDL (S.HDL.TG) particles also robustly increased the risk of CHD and MI by 9-28% and 9-27%, respectively. TG in very= extremely large VLDL (XXL.VLDL.TG and XL.VLDL.TG) were insignificant or even negatively associated with CHD (in multivariable TSMR), and negatively associated with IS as well. Conclusion: The remnant lipids presented heterogeneity and two-sided effects for the risk of CHD and IS that may partially rely on the particle size. The findings suggested that the remnant lipids were required to be intervened according to specific components. This research confirms the importance of remnant lipids and provides causal evidence for potential targets for intervention.
引用
收藏
页码:205 / 214
页数:10
相关论文
共 40 条
[11]   Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism [J].
Doi, H ;
Kugiyama, K ;
Oka, H ;
Sugiyama, S ;
Ogata, N ;
Koide, S ;
Nakamura, S ;
Yasue, H .
CIRCULATION, 2000, 102 (06) :670-676
[12]   Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel [J].
Ference, Brian A. ;
Ginsberg, Henry N. ;
Graham, Ian ;
Ray, Kausik K. ;
Packard, Chris J. ;
Bruckert, Eric ;
Hegele, Robert A. ;
Krauss, Ronald M. ;
Raal, Frederick J. ;
Schunkert, Heribert ;
Watts, Gerald F. ;
Boren, Jan ;
Fazio, Sergio ;
Horton, Jay D. ;
Masana, Luis ;
Nicholls, Stephen J. ;
Nordestgaard, Borge G. ;
van de Sluis, Bart ;
Taskinen, Marja-Riitta ;
Tokgozoglu, Lale ;
Landmesser, Ulf ;
Laufs, Ulrich ;
Wiklund, Olov ;
Stock, Jane K. ;
Chapman, M. John ;
Catapano, Alberico L. .
EUROPEAN HEART JOURNAL, 2017, 38 (32) :2459-2472
[13]   Remnant Lipoproteins Are Residual Risk Factor for Future Cardiovascular Events in Patients With Stable Coronary Artery Disease and On-Statin Low-Density Lipoprotein Cholesterol Levels <70 mg/dL [J].
Fujihara, Yuki ;
Nakamura, Takamitsu ;
Horikoshi, Takeo ;
Obata, Jun-ei ;
Fujioka, Daisuke ;
Watanabe, Yosuke ;
Watanabe, Kazuhiro ;
Kugiyama, Kiyotaka .
CIRCULATION JOURNAL, 2019, 83 (06) :1302-+
[14]   Childhood BMI and Adult Type 2 Diabetes, Coronary Artery Diseases, Chronic Kidney Disease, and Cardiometabolic Traits: A Mendelian Randomization Analysis [J].
Geng, Tingting ;
Smith, Caren E. ;
Li, Changwei ;
Huang, Tao .
DIABETES CARE, 2018, 41 (05) :1089-1096
[15]   Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes A Mendelian Randomization Study [J].
Hindy, George ;
Engstrom, Gunnar ;
Larsson, Susanna C. ;
Traylor, Matthew ;
Markus, Hugh S. ;
Melander, Olle ;
Orho-Melander, Marju .
STROKE, 2018, 49 (04) :820-+
[16]   Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke [J].
Hopewell, Jemma C. ;
Malik, Rainer ;
Valdes-Marquez, Elsa ;
Worrall, Bradford B. ;
Collins, Rory .
EUROPEAN HEART JOURNAL, 2018, 39 (05) :354-+
[17]   Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction [J].
Jorgensen, Anders Berg ;
Frikke-Schmidt, Ruth ;
West, Anders Sode ;
Grande, Peer ;
Nordestgaard, Borge G. ;
Tybjaerg-Hansen, Anne .
EUROPEAN HEART JOURNAL, 2013, 34 (24) :1826-+
[18]   Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA [J].
Kettunen, Johannes ;
Demirkan, Ayse ;
Wurtz, Peter ;
Draisma, Harmen H. M. ;
Haller, Toomas ;
Rawal, Rajesh ;
Vaarhorst, Anika ;
Kangas, Antti J. ;
Lyytikaeinen, Leo-Pekka ;
Pirinen, Matti ;
Pool, Rene ;
Sarin, Antti-Pekka ;
Soininen, Pasi ;
Tukiainen, Taru ;
Wang, Qin ;
Tiainen, Mika ;
Tynkkynen, Tuulia ;
Amin, Najaf ;
Zeller, Tanja ;
Beekman, Marian ;
Deelen, Joris ;
van Dijk, Ko Willems ;
Esko, Tonu ;
Hottenga, Jouke-Jan ;
van Leeuwen, Elisabeth M. ;
Lehtimaki, Terho ;
Mihailov, Evelin ;
Rose, Richard J. ;
de Craen, Anton J. M. ;
Gieger, Christian ;
Kahonen, Mika ;
Perola, Markus ;
Blankenberg, Stefan ;
Savolainen, Markku J. ;
Verhoeven, Aswin ;
Viikari, Jorma ;
Willemsen, Gonneke ;
Boomsma, Dorret I. ;
van Duijn, Cornelia M. ;
Eriksson, Johan ;
Jula, Antti ;
Jarvelin, Marjo-Riitta ;
Kaprio, Jaakko ;
Metspalu, Andres ;
Raitakari, Olli ;
Salomaa, Veikko ;
Slagboom, P. Eline ;
Waldenberger, Melanie ;
Ripatti, Samuli ;
Ala-Korpela, Mika .
NATURE COMMUNICATIONS, 2016, 7
[19]   Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017 [J].
Kinoshita, Makoto ;
Yokote, Koutaro ;
Arai, Hidenori ;
Iida, Mami ;
Ishigaki, Yasushi ;
Ishibashi, Shun ;
Umemoto, Seiji ;
Egusa, Genshi ;
Ohmura, Hirotoshi ;
Okamura, Tomonori ;
Kihara, Shinji ;
Koba, Shinji ;
Saito, Isao ;
Shoji, Tetsuo ;
Daida, Hiroyuki ;
Tsukamoto, Kazuhisa ;
Deguchi, Juno ;
Dohi, Seitaro ;
Dobashi, Kazushige ;
Hamaguchi, Hirotoshi ;
Hara, Masumi ;
Hiro, Takafumi ;
Biro, Sadatoshi ;
Fujioka, Yoshio ;
Maruyama, Chizuko ;
Miyamoto, Yoshihiro ;
Murakami, Yoshitaka ;
Yokode, Masayuki ;
Yoshida, Hiroshi ;
Rakugi, Hiromi ;
Wakatsuki, Akihiko ;
Yamashita, Shizuya .
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (09) :846-984
[20]   Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol [J].
Lawler, Patrick R. ;
Akinkuolie, Akintunde O. ;
Chu, Audrey Y. ;
Shah, Svati H. ;
Kraus, William E. ;
Craig, Damian ;
Padmanabhan, Latha ;
Glynn, Robert J. ;
Ridker, Paul M. ;
Chasman, Daniel I. ;
Mora, Samia .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (07)